Strides Arcolab sets up $30 mln facility in Brazil

New Delhi, May 11: Pharma company Strides Arcolab Ltd today said its subsidiary Cellofarm has set up a sterile injectable facility in Brazil at an investment of 30 million dollars.

Mr Elcemar Almeida, who heads the Latin American Operations, stated, ''This facility is an important expansion strategy for both the Brazilian operations and Strides group.'' The state-of-the-art-facility for Penems and Penicillins at Rio de Janeiro, will become a global site for the Strides group's growing sterile business.

''We are confident that the Brazilian operations will continue to play a significant role in the Strides growth strategy,'' he said in a statement.

UNI